Contact Nashville Saxenda Lawyer Timothy L. Miles today if you suffered Saxenda side effects about a Saxenda lawsuit
introduction If you suffered Saxenda side effects, call Nashville Saxenda lawyer Timothy L. Miles for a free case evaluation
Saxenda is a member of the glucagon-like peptide 1 (GLP-1) receptor agonists that delivers an active compound called liraglutide. Liraglutide was originally approved by the U.S. Food and Drug Administration (FDA) in 2010 as an adjunct therapy to diet and exercise for the management of type-2 diabetes sold under the brand name Victoza. After the release of clinical trial findings, Saxenda was granted authorization in 2017 as a weight loss treatment for individuals with a body mass index (BMI) exceeding 30, or with a BMI of 27 and above and also suffering from a metabolic disorder. However, Saxenda is not prescribed for the management of type 2 diabetes.
However, this glucagon-like peptide-1 (GLP-1) receptor agonist, like its counterparts Wegovy and Ozempic, has been linked to severe and potentially life-threatening Saxenda side effects, prompting a surge in Saxenda lawsuits. Those who took Saxenda and subsequently suffered severe Saxenda side effects including gastroparesis, gallbladder disease, kidney or suffered from Saxenda and persistent vomiting may be eligible for a Saxenda lawsuit and possibly entitled to substantial compensation. If you think you may be eligible for a Saxenda lawsuit, read on to find out more as we answer the six most frequently asked questions from consumers about a Saxenda lawsuit. what is the link between SAXENDA AND GASTROPARESIS?
Gastroparesis is a condition that affects the normal movement of the muscles in the stomach, causing delayed emptying of the stomach's contents. It can lead to symptoms such as nausea, vomiting, bloating, and abdominal pain. While various factors can contribute to the development of gastroparesis, recent studies have suggested a potential link between the use of Saxenda and gastroparesis and there has been an increase in the number of reports of individuals who developed gastroparesis after taking Saxenda.
While previous studies found a link between diabetics who take Glucagon-like peptide-1 receptor agonists and an increased risk of gastrointestinal side effects, another study examined the risks of people taking GLP-1 agonists strictly for weight loss such as Saxenda. The study included 613 patients taking Wegovy, Ozempic and Rybelsus and 4,144 taking Saxenda and compared them to 654 patients on bupropion-naltrexone (Contrave), a popular weight loss medication that is not a GLP-1 drug. The study also found that 11 of the patients on semaglutide and 372 patients on liraglutide faced gastrointestinal problems, compared to only 22 patients on bupropion-naltrexone. The study found that, compared to patients on Contrave, patients taking the two GLP-1 agonists, including Saxenda, had a 9.09 times greater risk of pancreatitis, 4.22 times greater risk of bowel obstruction, and a 3.67 times greater risk of gastroparesis, or stomach paralysis. Moreover, CNN recently reported that at least two people taking drugs in the same class as Saxenda, one taking Ozempic and the other taking Wegovy, have experienced more than just minor stomach issues; these individuals have been diagnosed with gastroparesis, or "paralyzed stomachs." In addition, Dr. Andrew Boxer, a gastroenterologist at Gastroenterology Associates of New Jersey, is among several gastroenterologists who said he is seeing an increased number of patients coming into his practice complaining of side effects from these types of drugs. In an article in Healthline, Dr. Boxer continued stating that "I was seeing a tremendous amount of people coming in just with nausea, vomiting, and feelings of fullness, early satiety, just not feeling well … Universally these patients were on GLP-1’s." Moreover, doctors have stated additional similar cases are coming to light as the popularity of these drugs has soared. The FDA said it has received reports through its adverse events tracking system of people on the drugs experiencing stomach paralysis that sometimes has not resolved by the time it is reported. Additionally, the American Society of Anesthesiologists warned that patients should stop GLP-1 agonists a week before surgery due to the increased risk that individuals will regurgitate food during surgery, even if they have fasted as directed. If someone vomits under anesthesia it can sometimes cause food and acid in the stomach to make their way into the lungs, possibly causing pneumonia and other similar problems after an operation. Dr. Shilpa Mehra Dang, a gastroenterologist at Medical Offices of Manhattan, stated: "It is very important for doctors and nurses to keep an eye on patients who are taking GLP-1 receptor agonist drugs for any signs of stomach problems, such as sickness, vomiting, bloating, and feeling full before they should. These are all symptoms of gastroparesis." The exact mechanism by which Saxenda may contribute to the development of gastroparesis is not yet fully understood. However, it is thought that the medication may affect the nerves and muscles in the stomach, leading to a disruption in gastric motility. This can result in the delayed emptying of food from the stomach, causing the symptoms associated with gastroparesis. It normally takes around six to eight hours for food to pass from the stomach to the small intestine. With gastroparesis, however. the digestion process is extended with the amount of extension differing from person to person. One study which was published in the Lancet Gastroenterology and Hepatology observed how liraglutide affected digestion. The participants in the study took either liraglutide or a placebo for five weeks and then ate a meal containing a radioactive tracer which allowed researchers to see how long the food stayed in their stomachs. For the individuals taking liraglutide, it took 70 minutes for half their food to leave their stomachs. In contrast, it took only four minutes in the control group, an extreme diversity in the slow-down in digestion. Additionally, for some participants taking liraglutide, it took up to two hours and 30 minutes for half the meal to leave their stomachs. It is important to note that not all individuals who take Saxenda will develop gastroparesis. The link between Saxenda and gastroparesis is still being studied, and further research is needed to determine the extent of this association. Additionally, there may be other factors at play that contribute to the development of gastroparesis in individuals who have taken Saxenda such as diabetes mellitus, Parkinson’s disease, following surgery, or with some medications. Notwithstanding, it cannot be seriously debated that there has been a steady increase in the number of individuals who took Saxenda and developed gastroparesis. Jaclyn Bjorklund had been prescribed Ozempic for the management of type-2 diabetes for more than a year before she was switched to Mounjaro. Bjorklund claims that her use of both Ozempic and Mounjaro resulted in severe gastrointestinal events, including “severe vomiting, stomach pain, gastrointestinal burning, being hospitalized for stomach issues on several occasions including visits to the emergency room, [and] teeth falling out due to excessive vomiting, requiring additional medications to alleviate her excessive vomiting and throwing up whole food hours after eating.” It is the increase in reported events like this that continues to rise in number that causes concern about the link between Saxenda and gastroparesis. A steady increase has been reported in the number of individuals having to be rushed to the emergency room and then for extended hospital stays because they took Saxenda developed gastroparesis. If you developed gastroparesis after taking Saxenda, it is crucial to consult with your healthcare provider. They can evaluate your symptoms, conduct necessary tests, and provide appropriate treatment options. It may be necessary to adjust your medication regimen or explore alternative treatments for managing weight loss. what about SAXENDA AND PERSISTENT VOMITING? If you suffered Saxenda and persistent vomiting, contact Saxenda lawyer Timothy L. Miles
One of the most serious and debilitating side effects of Saxenda is persistent vomiting along with gastroparesis. Gastroparesis is a condition that affects the normal movement of the muscles in the stomach, causing delayed emptying of the stomach's contents. This can lead to symptoms such as nausea, vomiting, bloating, and abdominal pain.
Recent studies have suggested a potential link between the use of Saxenda and the development of gastroparesis. A study examining the risks of people taking GLP-1 agonists for weight loss, including Saxenda, found that patients taking these medications had a 3.67 times greater risk of developing gastroparesis compared to those taking a different weight loss medication, Contrave. Moreover, healthcare professionals have reported an increase in the number of patients presenting with severe gastrointestinal issues, such as persistent vomiting, after starting Saxenda or similar GLP-1 agonist medications. These reports have raised significant concerns about the potential for Saxenda to contribute to the development of gastroparesis and other debilitating Saxenda side effects. If you suffered from Saxenda and persistent vomiting, call Saxenda lawyer Timothy L. Miles today for a free case evaluation. You may be eligible for a Saxenda lawsuit and possibly entitled to substantial compensation. Is There a Cure for Gastroparesis?
According to the Mayo Clinic, there is no known cure for gastroparesis, although withdrawal of the drug may bring an end to it. Gastroparesis can cause major complications in the body, like dehydration, malnutrition, and a decreased quality of life.
What Should I Do If I Suffered Gastroparesis or Other Saxenda Side Effects?
How Do I Know If I Am Eligible for a Saxenda Lawsuit?
If you have taken Saxenda, and are experiencing Saxenda side effects such as gastroparesis, kidney damage, gallbladder disease, or persistent vomiting, then you are most likely eligible for a Saxenda Lawsuit. Contact Saxenda lawyer Timothy L. Miles today who can answer any questions you have including whether you are eligible for a Saxenda Lawsuit. (855) 846–6529 or [email protected].
If I Suffered Saxenda Side Effects and Am Eligible for a Saxenda Lawsuit, How Much Money Can I Get?
If you are eligible for a Saxenda lawsuit, a successful plaintiff is entitled to compensatory damages which would include compensation for things such as:
If your case proceeds to trial it is also possible the court could impose punitive damages, intended to punish the defendant for their actions. Contact a Saxenda lawyer who can tell you if you are eligible for a Saxenda lawsuit and can explain more about the type of damages you are entitled to receive. IF YOU SUFFERED FROM SAXENDA SIDE EFFECTS, CONTACT SAXENDA LAWYER TIMOTHY L. MILES TODAY ABOUT A SAXENDA LAWSUIT
If you were prescribed Saxenda and took it as directed and developed gastroparesis after taking Saxenda, gallbladder disease, kidney damage, suffered Saxenda and persistent vomiting, or any other severe Saxenda side effects, contact Saxenda lawyer Timothy L. Miles today. You could be eligible for a Saxenda lawsuit and potentially entitled to substantial compensation.
The call is free and so is the fee unless we win or settle your case, so give a Saxenda lawyer a call today. (855) 846–6529 or [email protected].
The Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center 300 Centerview Dr., #247 Brentwood, TN 37027 Phone: (855) 846–6529 Email: [email protected] SAXENDA LAWYER TIMOTHY L. MILESNashville attorney Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles has dedicated his career to representing shareholders, employees, and consumers in complex class-action litigation. Whether serving as lead, co-lead, or liaison counsel, Mr. Miles has helped recover hundreds of millions of dollars for defrauded investors, shaped precedent-setting decisions, and delivered real corporate governance reforms. Judges and peers have repeatedly recognized Mr. Miles’ relentless advocacy for the underdog, as well as his unbendable ethical standards. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association,Class Action: Class Action: Top National Trial Lawyers, National Trial Lawyers Association (2023), a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019); a Top Rated Litigator by Martindale-Hubbell® and ALM (2019-2022); America’s Most Honored Lawyers 2020 – Top 1% by America’s Most Honored (2020-2022). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, civil procedure, derivative actions, corporate takeover litigation, corporate formation, mass torts, dangerous drugs, and more. Please visit our website or call for free anytime. Comments are closed.
|
Hours |
|
